Eye To Eye is focused on the digital transformation of glaucoma care to save vision for those afflicted. The Team has developed innovative technologies that dramatically enhance patient care and accessibility.

Norachem uses AI-based generative design to make novel drugs for specific diseases - from scratch. Using generative design to tailor molecules for specific diseases, their algorithms can access a region of near-infinite chemical space while simultaneously optimizing for ease of synthesis, low toxicity, and high binding affinity— resulting in faster, less expensive, and superior drug molecules.

Preamble is the next-gen performance and preventative medicine for those that want to live longer, healthier lives. Their mission is to catch health problems before they catch us. Focused on cutting-edge technology and grounded in personalization, Preamble is here to radically change health outcomes.

SOSV is a global venture capital firm that offers multi-stage investment starting in our deeply resourced, deep tech startup programs, IndieBio and HAX, with locations in New York City, Newark and San Francisco.